The Efficacy and Safety of Abelmoschus manihot for Reduction of Microalbuminuria in Patients with Type 2 Diabetes and Diabetic Nephropathy-A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Trial

被引：0
|
作者：
Yin, Jun
Chen, Si
Wei, Li
Jia, Weiping
机构：
来源：
DIABETES | 2023年 / 72卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.2337/db23-11-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial
    Han, Bingfeng
    Liu, Wu
    Du, Juan
    Liu, Hanyu
    Zhao, Tianshuo
    Yang, Shubo
    Wang, Shuai
    Zhang, Sihui
    Liu, Bei
    Liu, Yaqiong
    Cui, Fuqiang
    VACCINE, 2021, 39 (25) : 3365 - 3371
  • [22] Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial
    Cao, Yongsheng
    Cao, Shujie
    Zhao, Jiangang
    Zhao, Jianqin
    Zhao, Yanan
    Liu, Ying
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [23] Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial
    Nishimura, Akihiro
    Usui, Shuki
    Kumashiro, Naoki
    Uchino, Hiroshi
    Yamato, Azusa
    Yasuda, Daijiro
    Nagasawa, Kaoru
    Okubo, Minoru
    Mori, Yasumichi
    Hirose, Takahisa
    ENDOCRINE JOURNAL, 2016, 63 (12) : 1087 - 1098
  • [24] Clinical efficacy and feasibility of whey protein isolates supplementation in malnourished peritoneal dialysis patients: A multicenter, parallel, open-label randomized controlled trial
    Sahathevan, Sharmela
    Se, Chee-Hee
    Ng, SeeHoe
    Khor, Ban-Hock
    Chinna, Karuthan
    Goh, Bak Leong
    Gafor, Halim A.
    Bavanandan, Sunita
    Ahmad, Ghazali
    Karupaiah, Tilakavati
    CLINICAL NUTRITION ESPEN, 2018, 25 : 68 - 77
  • [25] Two-Year Efficacy and Safety of AIR Inhaled Insulin in Patients with Type 1 Diabetes: An Open-Label Randomized Controlled Trial
    Garg, Satish K.
    Mathieu, Chantal
    Rais, Nadeem
    Gao, Haitao
    Tobian, Janet A.
    Gates, Jeffrey R.
    Ferguson, Jeffrey A.
    Webb, David M.
    Berclaz, Pierre-Yves
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 : S5 - S16
  • [26] SAFETY AND EFFICACY OF MCC-257 IN DIABETIC PERIPHERAL NEUROPATHY: RESULTS OF A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL AND OPEN-LABEL EXTENSION
    Polydefkis, M.
    Arezzo, J.
    Katayama, S.
    Vinik, A., I
    Altman, H.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S110 - S110
  • [27] Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial
    Yang, Xue
    He, Zhiwei
    Yuan, Li
    Huang, Wenbin
    Li, Doudou
    Xiang, Pingping
    Chen, Yu
    Chen, Guofang
    Liu, Chao
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [28] Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial
    Xue Yang
    Zhiwei He
    Li Yuan
    Wenbin Huang
    Doudou Li
    Pingping Xiang
    Yu Chen
    Guofang Chen
    Chao Liu
    BMC Endocrine Disorders, 23
  • [29] Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial
    Dong, Zheyi
    Zhou, Jianhui
    Xu, Zhonggao
    Ni, Zhaohui
    He, Yani
    Lin, Hongli
    Jiang, Gengru
    Sun, Xuefeng
    Zhang, Li
    Chen, Xiangmei
    JMIR RESEARCH PROTOCOLS, 2023, 12
  • [30] The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes A Multicenter, Parallel-Group, Open-Label Randomized Clinical Trial
    Poole, Alexis P.
    Finnis, Mark E.
    Anstey, James
    Bellomo, Rinaldo
    Bihari, Shailesh
    Biradar, Vishwanath
    Doherty, Sarah
    Eastwood, Glenn
    Finfer, Simon
    French, Craig J.
    Heller, Simon
    Horowitz, Michael
    Kar, Palash
    Kruger, Peter S.
    Maiden, Matthew J.
    Martensson, Johan
    McArthur, Colin J.
    McGuinness, Shay P.
    Secombe, Paul J.
    Tobin, Antony E.
    Udy, Andrew A.
    Young, Paul J.
    Deane, Adam M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (07) : 874 - 882
12345